Pulse Therapeutics is proud to announce its merger with ICHOR Vascular and the subsequent creation of Euphrates Vascular. For more information, contact CEO Sean Morris.

Pulse Therapeutics’ MED System Featured by Horizon Scanning Research & Intelligence Centre

The Horizon Scanning Research & Intelligence Centre (HSRIC), a research programme within the National Institute for Health Research (NIHR), has published a technology alert about the Magnetically-Enhanced Diffusion (MED) System™ in development by Pulse Therapeutics, Inc.

The alert shares how the MED System is designed to improve the delivery of thrombolytic therapy in people who have had an acute ischaemic stroke by using intravenously-injected iron nanoparticles and an externally positioned rotating magnetic field.

The technology alert covers technology, potential for impact and evidence.

For almost 20 years, the HSRIC team supplied information to key NHS policy and decision-makers and research funders about emerging health technologies that may have a significant impact on patients or the provision of health services in the near future.

Download the HSRIC Technology Alert on the MED System

Read More on HSRIC’s website

Posted in